Basel Medical Group (NASDAQ:BMGL) vs. Intelligent Bio Solutions (NASDAQ:INBS) Head to Head Contrast

Basel Medical Group (NASDAQ:BMGLGet Free Report) and Intelligent Bio Solutions (NASDAQ:INBSGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership.

Profitability

This table compares Basel Medical Group and Intelligent Bio Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Basel Medical Group N/A N/A N/A
Intelligent Bio Solutions -296.73% -176.09% -89.71%

Risk and Volatility

Basel Medical Group has a beta of 0.07, meaning that its stock price is 93% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.24, meaning that its stock price is 324% more volatile than the S&P 500.

Institutional & Insider Ownership

33.0% of Intelligent Bio Solutions shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Basel Medical Group and Intelligent Bio Solutions”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Basel Medical Group $8.90 million 1.25 -$9.50 million N/A N/A
Intelligent Bio Solutions $3.05 million 2.01 -$10.57 million ($12.22) -0.21

Basel Medical Group has higher revenue and earnings than Intelligent Bio Solutions.

Analyst Recommendations

This is a summary of current recommendations and price targets for Basel Medical Group and Intelligent Bio Solutions, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Basel Medical Group 1 0 0 0 1.00
Intelligent Bio Solutions 1 0 0 0 1.00

Summary

Basel Medical Group beats Intelligent Bio Solutions on 5 of the 9 factors compared between the two stocks.

About Basel Medical Group

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

About Intelligent Bio Solutions

(Get Free Report)

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.